Abstract

The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained from previous outbreaks, perhaps the world is better equipped to deal with the most recent emergent group 2B coronavirus.

Keywords

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus2019-20 coronavirus outbreakOutbreakVirologyBetacoronavirusSevere acute respiratory syndrome coronavirusCoronavirus InfectionsPandemicPneumoniaGeographyBiologyMedicineInfectious disease (medical specialty)PathologyDisease

MeSH Terms

AnimalsBetacoronavirusCOVID-19ChinaCommunicable DiseasesEmergingCoronavirus InfectionsDisease OutbreaksDisease ReservoirsDisease SusceptibilityGenomeViralHumansNucleocapsid ProteinsPneumoniaViralSevere acute respiratory syndrome-related coronavirusSARS-CoV-2Severe Acute Respiratory SyndromeSocial MediaSpike GlycoproteinCoronavirusZoonoses

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
article
Volume
12
Issue
2
Pages
135-135
Citations
1421
Access
Closed

Social Impact

Altmetric

Social media, news, blog, policy document mentions

Citation Metrics

1421
OpenAlex
52
Influential
939
CrossRef

Cite This

Lisa E. Gralinski, Vineet D. Menachery (2020). Return of the Coronavirus: 2019-nCoV. Viruses , 12 (2) , 135-135. https://doi.org/10.3390/v12020135

Identifiers

DOI
10.3390/v12020135
PMID
31991541
PMCID
PMC7077245

Data Quality

Data completeness: 86%